BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More

BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More
The biological mechanisms governing the transition of blood stem cells from a dormant state to an active, regenerative phase have…
Read More
In a significant advancement for the field of hematology and regenerative medicine, researchers at Weill Cornell Medicine have identified a…
Read More